Compile Data Set for Download or QSAR
Report error Found 74 of ph data with Target = 'Beta-2 adrenergic receptor'
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 27960BDBM27960(CHEMBL198059 | (2R,3S)-1-[(7-methyl-2,3-dihydro-1H...)
Affinity DataKi:  1nM ΔG°:  -50.9kJ/mole IC50: 3nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 27958BDBM27958(Planipart | 1-(4-amino-3,5-dichlorophenyl)-2-(tert...)
Affinity DataKi:  570nM ΔG°:  -35.3kJ/mole IC50: 1.30E+3nM EC50:  6.20nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 27955BDBM27955((9R,10R)-9-hydroxy-10-(propan-2-ylamino)-1,3-diaza...)
Affinity DataKi:  320nM ΔG°:  -36.7kJ/mole IC50: 620nM EC50:  8.70nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 27959BDBM27959(El 737 | 4-(1-hydroxy-2-{[4-(4-hydroxyphenyl)butan...)
Affinity DataKi:  180nM ΔG°:  -38.1kJ/mole IC50: 330nM EC50:  9.10nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 27956BDBM27956(9-hydroxy-10-(propan-2-ylamino)-1,3-diazatricyclo[...)
Affinity DataKi:  580nM ΔG°:  -35.2kJ/mole IC50: 1.10E+3nM EC50:  13nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 25769BDBM25769(Levalbuterol | Salbutamol,(+/-) | albuterol | Prov...)
Affinity DataKi:  510nM ΔG°:  -35.6kJ/mole IC50: 980nM EC50:  19nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 25392BDBM25392(Isoproterenol,(+) | CHEMBL434 | 4-[1-hydroxy-2-(pr...)
Affinity DataKi:  136nM ΔG°:  -38.8kJ/molepH: 7.4 T: 2°CAssay Description:The displacement of [125I]-(-)iodopindolol binding from the beta2AR was determined using DDT1 MF-2 cell membranes. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2008
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213115BDBM50213115((R,R)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKd:  240nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213115BDBM50213115((R,R)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  241nM ΔG°:  -35.1kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 25398BDBM25398(N-[5-(2-{[6-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hy...)
Affinity DataKi:  311nM ΔG°:  -36.8kJ/molepH: 7.4 T: 2°CAssay Description:The displacement of [125I]-(-)iodopindolol binding from the beta2AR was determined using DDT1 MF-2 cell membranes. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2008
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213110BDBM50213110((R,S)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKd:  339nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213110BDBM50213110((R,S)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  341nM ΔG°:  -34.3kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213098BDBM50213098((R,R)-(-)-fenoterol | US9492405, (R,R)-1 | CHEMBL3...)
Affinity DataKi:  345nM ΔG°:  -34.3kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213098BDBM50213098((R,R)-(-)-fenoterol | US9492405, (R,R)-1 | CHEMBL3...)
Affinity DataKd:  347nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213099BDBM50213099((R,R)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  474nM ΔG°:  -33.6kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213099BDBM50213099((R,R)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKd:  479nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 25396BDBM25396(N-[5-(2-{[4-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hy...)
Affinity DataKi:  863nM ΔG°:  -34.3kJ/molepH: 7.4 T: 2°CAssay Description:The displacement of [125I]-(-)iodopindolol binding from the beta2AR was determined using DDT1 MF-2 cell membranes. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2008
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213096BDBM50213096((S,R)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKd:  1.78E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213096BDBM50213096((S,R)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  1.78E+3nM ΔG°:  -30.5kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 206771BDBM206771((R,R)-4 | US9492405, (R,R)-4)
Affinity DataKd:  1.86E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 206771BDBM206771((R,R)-4 | US9492405, (R,R)-4)
Affinity DataKi:  1.86E+3nM ΔG°:  -30.4kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213120BDBM50213120((R,S)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  1.93E+3nM ΔG°:  -30.3kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213120BDBM50213120((R,S)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKd:  1.95E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 25399BDBM25399(N-[5-(1-{9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxy...)
Affinity DataKi:  2.30E+3nM ΔG°:  -31.9kJ/molepH: 7.4 T: 2°CAssay Description:The displacement of [125I]-(-)iodopindolol binding from the beta2AR was determined using DDT1 MF-2 cell membranes. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2008
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213101BDBM50213101((S,S)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKd:  2.51E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213101BDBM50213101((S,S)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  2.54E+3nM ΔG°:  -29.7kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213108BDBM50213108((R,R)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  2.93E+3nM ΔG°:  -29.4kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213108BDBM50213108((R,R)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKd:  2.95E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213106BDBM50213106((R,S)-(-)-fenoterol | US9492405, (R,S)-1 | CHEMBL2...)
Affinity DataKi:  3.70E+3nM ΔG°:  -28.8kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213106BDBM50213106((R,S)-(-)-fenoterol | US9492405, (R,S)-1 | CHEMBL2...)
Affinity DataKd:  3.72E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 25397BDBM25397((2R,3R,4S,5R)-2-{6-[(4-{[2-(3-amino-4-hydroxypheny...)
Affinity DataKi:  4.31E+3nM ΔG°:  -30.3kJ/molepH: 7.4 T: 2°CAssay Description:The displacement of [125I]-(-)iodopindolol binding from the beta2AR was determined using DDT1 MF-2 cell membranes. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2008
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 206769BDBM206769( (S,R)-2 | US9492405, (S,R)-2)
Affinity DataKd:  5.25E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 206769BDBM206769( (S,R)-2 | US9492405, (S,R)-2)
Affinity DataKi:  5.27E+3nM ΔG°:  -28.0kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 206772BDBM206772((R,S)-4 | US9492405, (R,S)-4)
Affinity DataKd:  6.03E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 206772BDBM206772((R,S)-4 | US9492405, (R,S)-4)
Affinity DataKi:  6.04E+3nM ΔG°:  -27.7kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 27957BDBM27957((9S,10S)-9-hydroxy-10-(propan-2-ylamino)-1,3-diaza...)
Affinity DataEC50:  6.90E+3nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/5/2009
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213112BDBM50213112((R,S)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  7.94E+3nM ΔG°:  -27.1kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213112BDBM50213112((R,S)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKd:  7.94E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 206775BDBM206775((R,R)- 6 | US9492405, (R,R)-6)
Affinity DataKi:  9.28E+3nM ΔG°:  -26.7kJ/molepH: 7.8 T: 2°CAssay Description:Beta1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 206775BDBM206775((R,R)- 6 | US9492405, (R,R)-6)
Affinity DataKd:  9.33E+3nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 86556BDBM86556(Azanium analog, 28)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:Affinities for D3-dopaminergic, D2-dopaminergic and beta2-adrenergic receptors were determined by radioligand competition binding at the National Ins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2012
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 25394BDBM25394(N-[5-(2-{[2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hy...)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:The displacement of [125I]-(-)iodopindolol binding from the beta2AR was determined using DDT1 MF-2 cell membranes. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2008
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 86550BDBM86550(Piperidin-1-ium analog, 2)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:Affinities for D3-dopaminergic, D2-dopaminergic and beta2-adrenergic receptors were determined by radioligand competition binding at the National Ins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2012
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 25395BDBM25395((2R,3R,4S,5R)-2-{6-[(2-{[2-(3-amino-4-hydroxypheny...)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:The displacement of [125I]-(-)iodopindolol binding from the beta2AR was determined using DDT1 MF-2 cell membranes. Nonspecific binding was determined...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2008
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 86551BDBM86551(Azanium analog, 3)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:Affinities for D3-dopaminergic, D2-dopaminergic and beta2-adrenergic receptors were determined by radioligand competition binding at the National Ins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2012
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 86554BDBM86554(Azanium analog, 6)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:Affinities for D3-dopaminergic, D2-dopaminergic and beta2-adrenergic receptors were determined by radioligand competition binding at the National Ins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2012
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 86555BDBM86555(Piperazin-1-ium analog, 7)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:Affinities for D3-dopaminergic, D2-dopaminergic and beta2-adrenergic receptors were determined by radioligand competition binding at the National Ins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2012
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 86552BDBM86552(Piperidin-1-ium analog, 4)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:Affinities for D3-dopaminergic, D2-dopaminergic and beta2-adrenergic receptors were determined by radioligand competition binding at the National Ins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2012
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 86553BDBM86553(Piperidin-1-ium analog, 5)
Affinity DataKi: >1.00E+4nM ΔG°: >-28.3kJ/molepH: 7.4 T: 2°CAssay Description:Affinities for D3-dopaminergic, D2-dopaminergic and beta2-adrenergic receptors were determined by radioligand competition binding at the National Ins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2012
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Intervet Innovation

LigandChemical structure of BindingDB Monomer ID 50213103BDBM50213103((S,R)-(+)-fenoterol | US9492405, (S,R)-1 | CHEMBL2...)
Affinity DataKd:  1.02E+4nMpH: 7.7Assay Description:HEK 293 cells stability transfected with cDNA encoding human beta2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) wer...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2016
Entry Details
US Patent

Displayed 1 to 50 (of 74 total ) | Next | Last >>
Jump to: